Reporting Bias in Clinical Trials Investigating the Efficacy of Second-Generation Antidepressants in the Treatment of Anxiety Disorders
- 1 May 2015
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Psychiatry
- Vol. 72 (5) , 500-10
- https://doi.org/10.1001/jamapsychiatry.2015.15
Abstract
Research from JAMA Psychiatry — Reporting Bias in Clinical Trials Investigating the Efficacy of Second-Generation Antidepressants in the Treatment of Anxiety Disorders — A Report of 2 Meta-analysesKeywords
This publication has 4 references indexed in Scilit:
- Faculty Opinions recommendation of Antidepressant drug effects and depression severity: a patient-level meta-analysis.Published by H1 Connect ,2010
- A Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dose Study of Venlafaxine Extended Release Capsules in Adult Outpatients With Panic DisorderThe Journal of Clinical Psychiatry, 2009
- A Randomized Controlled Trial of Venlafaxine Extended Release in Generalized Social Anxiety DisorderThe Journal of Clinical Psychiatry, 2005
- A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder.The Journal of Clinical Psychiatry, 2002